Dashboard
Manage Tickers

CMRX


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

top-3-health-care-stocks-that-may-crash-in-q2
Top 3 Health Care Stocks That May Crash In Q2
04/07/2025 15:23:04

chimerix-q4-2024-gaap-eps-025-beats-026-estimate-sales-5700k-miss-7500k-estimate
Chimerix Q4 2024 GAAP EPS $(0.25) Beats $(...
03/21/2025 10:04:57

Chimerix (NASDAQ:CMRX) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.26) by 3...

Core News & Articles
This MongoDB Analyst Is No Longer Bullish;...
03/06/2025 14:39:00

jones-trading-downgrades-chimerix-to-hold-announces-855-price-target
Jones Trading Downgrades Chimerix to Hold,...
03/06/2025 11:27:42

Jones Trading analyst Soumit Roy downgrades Chimerix (NASDAQ:CMRX) from Buy to Hold and announces $8.55 price target.

jefferies-downgrades-chimerix-to-hold-lowers-price-target-to-85
Jefferies Downgrades Chimerix to Hold, Low...
03/05/2025 21:46:11

Jefferies analyst Maury Raycroft downgrades Chimerix (NASDAQ:CMRX) from Buy to Hold and lowers the price target from $10 to ...

demystifying-chimerix-insights-from-4-analyst-reviews
Demystifying Chimerix: Insights From 4 Ana...
03/05/2025 19:00:28

hc-wainwright--co-downgrades-chimerix-to-neutral-lowers-price-target-to-855
HC Wainwright & Co. Downgrades Chimerix to...
03/05/2025 16:49:51

HC Wainwright & Co. analyst Edward White downgrades Chimerix (NASDAQ:CMRX) from Buy to Neutral and lowers the price targ...

jazz-pharma-to-buy-chimerix-for-935-million-strengthening-rare-cancer-pipeline
Jazz Pharma To Buy Chimerix For $935 Milli...
03/05/2025 13:41:43

Jazz Pharmaceuticals will add dordaviprone, a potential treatment for a rare brain tumor, to its growing oncology pipeline.

trading-halt-halt-status-updated-at-72500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 7:25:...
03/05/2025 12:25:04

Core News & Articles
Jazz Pharmaceuticals To Acquire Chimerix F...
03/05/2025 12:04:47

trading-halt-halted-at-65500-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 6:55:00 a.m. ET - ...
03/05/2025 11:55:04

hc-wainwright--co-reiterates-buy-on-chimerix-maintains-11-price-target
HC Wainwright & Co. Reiterates Buy on Chim...
02/18/2025 18:04:14

HC Wainwright & Co. analyst Edward White reiterates Chimerix (NASDAQ:CMRX) with a Buy and maintains $11 price target.

chimerix-secures-fda-priority-review-for-dordaviprone-advancing-potential-first-treatment-for-recurrent-h3-k27m-mutant-diffuse-glioma
Chimerix Secures FDA Priority Review For D...
02/18/2025 12:33:03

Potential First Approval for Patients with Recurrent H3 K27M-mutant Diffuse GliomaPDUFA Target Action Date of August 18, 2025No...

Core News & Articles
"New Case Of Mpox Detected In The UK After...
01/27/2025 17:50:29

https://www.manchestereveningnews.co.uk/news/health/new-case-mpox-detected-uk-30876004 A new case of Mpox has been confirmed in...

a-glimpse-into-the-expert-outlook-on-chimerix-through-4-analysts
A Glimpse Into The Expert Outlook On Chime...
12/30/2024 18:00:12

hc-wainwright--co-reiterates-buy-on-chimerix-maintains-11-price-target
HC Wainwright & Co. Reiterates Buy on Chim...
12/30/2024 15:35:17

HC Wainwright & Co. analyst Edward White reiterates Chimerix (NASDAQ:CMRX) with a Buy and maintains $11 price target.

chimerix-confirms-that-it-has-submitted-new-drug-application-with-fda-seeking-accelerated-approval-for-dordaviprone-as-treatment-for-patients-with-recurrent-h3-k27m-mutant-diffuse-glioma-in-us
Chimerix Confirms That It Has Submitted Ne...
12/30/2024 12:10:57

chimerix-seeks-fda-approval-for-new-drug-targeting-deadly-brain-cancer
Chimerix Seeks FDA Approval for New Drug T...
12/30/2024 12:01:28

Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and exte...

hc-wainwright--co-reiterates-buy-on-chimerix-maintains-11-price-target
HC Wainwright & Co. Reiterates Buy on Chim...
12/11/2024 11:30:19

HC Wainwright & Co. analyst Edward White reiterates Chimerix (NASDAQ:CMRX) with a Buy and maintains $11 price target.

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
12/10/2024 21:05:50

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION